Skip to main content
OpenTrials
Completed

NCT Number: NCT02733237

Oxytocin Effects on the Tolerance of Infidelity

To investigate whether intranasal oxytocin (40 IU) treatment can influence the tolerance of infidelity in males and females.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

19 year–28 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

China, Sichuan

Chengdu, Sichuan, 611731, China

About this study

In a double-blind, between-subject, placebo controlled design, investigators plan to investigate the effect of oxytocin treatment on the tolerance of infidelity. Male and female subjects would firstly see a neutral face of the opposite sex presented with a sentence descried their fidelity or infidelity behavior (sexual or emotional) in a relationship. Next the participant will rate the attractiveness, likability and trustworthiness of each individual, and whether they would like to have a short/long relationship with him/her. After that there will be some implicit attitude tasks to test their implicit attitude towards potential partners exhibiting previous fidelity or and infidelity.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy subjects without past or current psychiatric or neurological disorders

Exclusion criteria

  • history of head injury;
  • pregnant,menstruating,taking oral contraceptives
  • medical or psychiatric illness.

Treatment and study plan

oxytocin treatment

Drug

intranasal administration of oxytocin (40 IU)

placebo treatment

Drug

intranasal administration of placebo (40 IU)

Primary outcomes

  1. attitude towards fidelity and infidelity of potential mate.

    Time frame: 1 hour

    attitude is measured by the rating scores for likability, attractiveness and trustworthiness

Sponsors and collaborators

Lead sponsor

University of Electronic Science and Technology of China

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Apr 11, 2016
Registry last updated
Mar 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.